Block 3 Drugs Flashcards
Atropine
Muscarinic antagonist
Uses:
- preanesthetic to prevent respiratory secretions
- to treat sinus bradycardia
- blockade of excessive muscarinic receptor activation
Sites of action:
- heart - high dose can cause tachy
- lungs - causes bronchodilation, decreased secretion
- GI - decreased motility
- glands - decreased salivation and sweating
Busiprone
5-HT1A partial agonist
Use:
- treating dyspepsia (upset stomach/indigestion)
- an anxiolytic for anxiety disorders
Mechanisms:
- induces relaxation of proximal stomach
Cimetidine
Histamine H2 receptor antagonist
Use:
- for duodenal/gastric ulcers
- hypersecretion of acid
- GERD
Mechanisms:
- inhibits acid secretion into stomach
Notes:
- inhibitor of many isozymes of the cytochrome P450 enzyme system (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4)
Erythromycin
Macrolide antibiotic; motilin receptor agonist
Use:
- treating resp. tract + soft tissue infections
- treating gastroparesis (delayed gastric emptying) due to its pro-motility effect
Mechanisms:
- binds to 50s ribosomal subunit thus inhibiting bacterial protein synthesis
- as a motilin receptor agonist by direct muscular and indirect NT effects to stimulate GI motility
Fluoxetine
SSRI antidepressant
Used to treat:
- depression
- obsessive compulsive disorder
- bulimia nervosa
Mechanism:
- selective serotonin reuptake inhibitor (SSRI) at all SERT sites, in both CNS and PNS
Metoclopramide
5-HT3 antagonist; 5-HT4 agonist; dopamine D2 receptor antagonist; prokinetic drug
Use:
- treating reflux esophagitis
- for pre-op gastric emptying
- reduces chemotherapy-induced nausea
- an antiemetic
- is prokinetic (enhances GI motility)
Mechanisms:
- 5-HT3 antagonist
- 5-HT4 agonist
- Metoclopramide is a dopamine D2 receptor antagonist in CNS + PNS
- Dopamine D2 receptors inhibit ACh release (ACh is needed for gut motility)
- indirectly increases ACh release in gut
Misoprostol
Synthetic oral prostaglandin E1 analog
Use:
- for preventing gastric and duodenal ulcers secondary to use of NSAIDS, but currently indicated only for prevention of gastric ulcers
Mechanism:
- exerts a mucosal protectant effect. Its cytoprotective effect is secondary to: mucus and bicarb secretion, prevention of mucus bilayer disruption, reduction of backflow of H+, regulation of mucosal blood flow
Neostigmine
Carbamate-type peripheral cholinesterase inhibitor
Use:
- for myasthenia gravis dx and treatment
- paralytic ileus (neostigmine increases gastric motility)
- lack of bladder tone
- reversal of neuromuscular blockade following anesthesia
Notes:
- carbamate-type acetylcholinesterase inhibitor in periphery
Octreotide
Synthetic analog of somatostatin
Use:
- treating diarrhea, other abdominal illness
- for intestinal tumors, vasoactive intestinal peptide tumors, metastatic carcinoid tumors, acromegaly (excess growth hormone), variceal bleeding, orthostatic hypotension
Mechanisms:
- antidiarrheal - mimics somatostatin pharmacologically
- inhibits gastric acid and pepsin secretion
- reduces GI motility
- Inhibits contraction of gallbladder and bile flow
- reduces liver blood flow
Omeprazole
Proton pump inhibitor (PPI)
Used to treat:
- gastroesophageal reflux disease
- duodenal ulcer
- hypersecretory states (Zollinger-Ellison syndrome)
Mechanism:
- blocks acid secretion by irreversibly inhibiting the H+/K+ ATPase in parietal cells
Ondansetron
5-HT3 antagonist
Use:
- a prophylactic used to treat nausea and vomiting following chemotherapy
- for postoperative vomiting
Mechanism:
- 5-HT3 serotonin receptor antagonist
- its effects are BOTH in periphery and at chemotrigger zone (CTZ, an area of brain that receives input from blood-borne drugs or hormones)
Notes:
- granisetron is in the same class
Ranitidine
Histamine H2 receptor antagonist
Used to treat:
- duodenal/gastric ulcer
- hypersecretion of acid
- GERD (gastroesophageal reflux disease)
Mechanism:
- inhibits secretion of acid in stomach
- more potent than cimetidine
Notes:
- fewer side effects of cimetidine
Sulcralfate
Cytoprotectant; mucosal coating agent
Used to treat:
- gastric, duodenal, and stress ulcers
Mechanisms:
- acts locally (not systemically) to complex with proteins at ulcer site
- forms protective, viscous, adhesive barrier on surface of intact mucosa of stomach and duodenum
- inhibits pepsin activity
Sumatriptan
5-HT1B/1D receptor and 5-HT1P receptor agonist
Used to treat:
- functional dyspepsia with impaired accommodation
- acute migraine
- cluster headache attacks
Mechanism:
- Its peripheral actions include fundal relaxation and reductions in antral motility
- as a 5-HT1B/1D receptor agonist it causes vasoconstriction
Insulin
Always give insulin to diabetics REGARDLESS OF GLUCOSE LEVELS b/c lack of it can result in life-threatening ketoacidosis.
If glucose is low, give insulin + glucose to avoid ketoacidosis.
Insulin acts on receptors which, through a cascade, lead to increased amounts of GLUT 4 (glucose transporters) on the cell membrane.
Causes weight gain.
Metformin
First choice drug to treat Type 2 DM
It makes the liver more sensitive to insulin (“hearing aid for the liver”).
Inhibits gluconeogenesis.
Enhances GLUT 4 translocation (GLUT 4 then brings in glucose from blood into cells)
Makes people eat less.
Decreases risk of cancer.